HIV-1 Vpr is targeted for degradation by autophagy
PLOS Pathogens · 02.03.2026 · 22 (3) · e1014020
DOI: 10.1371/journal.ppat.1014020 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 02.03.2026. Verfasst von Yuexuan Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology. University of Rochester Medical Center. Rochester, New York, United States of America. Hauptthemen laut MEDLINE: Autophagy, HIV-1, vpr Gene Products, Human Immunodeficiency Virus, HIV Infections. Die Arbeit nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, School of Medicine and Dentistry, University of Rochester.
Abstract (Originalsprache)
Autophagy is part of the innate immune arsenal to fight viruses, including HIV-1. We previously reported that HIV-1 Gag is targeted for autophagy-mediated degradation. Here, we identify HIV-1 Vpr, an important virulence factor, as an autophagy target in HIV-1 NL4–3, a lab adapted molecular clone. Notably, Vpr proteins from a collection of transmitted/founder viruses (TFVs) were resistant to autophagy. Based on this observation, we identified residues at positions 37, 45, 77, 83–86, 93–94 in NL4–3 Vpr as responsible for its susceptibility to autophagy. Importantly, differences between NL4–3 and TFV Vpr proteins at these positions impact their interaction with the autophagy receptors NDP52, SQSTM1/p62 and TAX1BP1. By engineering NL4–3 molecular clones harboring either autophagy-sensitive or -resistant vpr , we found that in 2D and 3D in vitro systems virus spread was significantly reduced for the virus carrying autophagy-sensitive Vpr. In conclusion, our study identifies Vpr as a novel autophagy target and suggests that Vpr susceptibility to autophagy impacts HIV-1 spread.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology. University of Rochester Medical Center. Rochester, New York, United States of America.
- Institute of Molecular Virology, University of Ulm, Ulm, Germany.
- Department of Medicine, Infectious Diseases, Heersink School of Medicine. University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
- German Center for Neurodegenerative Diseases (DZNE), Ulm, Germany.
ORCID-Profile: Ruth Serra-Moreno
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- School of Medicine and Dentistry, University of Rochester
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Chen, Y., Klute, S., Bansal, A., Sparrer, K. M. J., & Serra-Moreno, R. (2026). HIV-1 Vpr is targeted for degradation by autophagy. PLOS Pathogens, 22(3), e1014020. https://doi.org/10.1371/journal.ppat.1014020
Vancouver
Chen Y, Klute S, Bansal A, Sparrer KMJ, Serra-Moreno R. HIV-1 Vpr is targeted for degradation by autophagy. PLOS Pathogens. 2026;22(3):e1014020. doi:10.1371/journal.ppat.1014020
BibTeX
@article{Chen2026,
author = {Chen, Yuexuan and Klute, Susanne and Bansal, Anju and Sparrer, Konstantin Maria Johannes and Serra-Moreno, Ruth},
title = {HIV-1 Vpr is targeted for degradation by autophagy},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {3},
pages = {e1014020},
doi = {10.1371/journal.ppat.1014020}
}
EUVIMED